These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2200898)

  • 1. [Aspects of new drug development].
    Arai Y; Urata Y
    Nihon Rinsho; 1990 Jun; 48(6):1327-35. PubMed ID: 2200898
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart.
    Ito T; Toki Y; Hieda N; Okumura K; Hashimoto H; Ogawa K; Satake T
    Jpn Circ J; 1989 Sep; 53(9):1115-21. PubMed ID: 2513429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of eicosanoids in reperfusion injury in rat liver transplantation.
    Post S; Palma P; Gonzalez AP; Rentsch M; Otto G; Menger MD
    Transplant Proc; 1993 Aug; 25(4):2547. PubMed ID: 8356663
    [No Abstract]   [Full Text] [Related]  

  • 4. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic arterial occlusive diseases--drug therapy and thromboxane A2 synthetase inhibitor].
    Yasuda K; Matsui Y; Goda T; Sakuma M; Go K
    Nihon Rinsho; 1991 Sep; 49(9):2149-54. PubMed ID: 1960880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibitor of thromboxane A2 synthesis as anticoagulant in hemodialysis].
    Iida N
    Nihon Rinsho; 1991 Dec; 49 Suppl():746-52. PubMed ID: 1839689
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective thromboxane synthase inhibition does not increase in vivo synthesis of prostacyclin in healthy humans.
    Vesterqvist O; Gréen K; Henriksson P; Rasmanis G; Edhag O
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():165-8. PubMed ID: 1825536
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective effects of selective inhibitor of thromboxane synthetase (OKY-046) and thromboxane antagonist (ONO-3708) on ischemia-induced mitochondrial dysfunction in canine heart.
    Ito T; Ito Y; Torii T; Hieda N; Toki Y; Miyazaki Y; Hashimoto H; Ogawa K; Satake T
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():392-6. PubMed ID: 2959085
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism between a phosphodiesterase inhibitor and modulators of thromboxane formation on thrombin-induced sudden death in rabbits.
    Smith EF; Olson RW
    Prog Clin Biol Res; 1987; 242():241-6. PubMed ID: 3671385
    [No Abstract]   [Full Text] [Related]  

  • 12. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191.
    Humphrey PP; Hallet P; Hornby EJ; Wallis CJ; Collington EW; Lumley P
    Circulation; 1990 Jan; 81(1 Suppl):I42-52; discussion I59-60. PubMed ID: 2136817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a specific thromboxane synthetase inhibitor in equine endotoxaemia.
    Semrad SD; Moore JN
    Res Vet Sci; 1987 Sep; 43(2):137-42. PubMed ID: 3317581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin--experimental and clinical approach.
    Gryglewski R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():457-61. PubMed ID: 6221563
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of thromboxane metabolism interference on glycemia regulation in rats.
    Nechifor M; Busuioc A; Cocu F
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(3):555-7. PubMed ID: 2977856
    [No Abstract]   [Full Text] [Related]  

  • 17. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
    Gorman RR; Fitzpatrick FA; Miller OV
    Adv Cyclic Nucleotide Res; 1978; 9():597-609. PubMed ID: 208399
    [No Abstract]   [Full Text] [Related]  

  • 18. Developments of TXA2 antagonists.
    Hamanaka N
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():663-5. PubMed ID: 2526556
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. A review.
    Fiddler GI; Lumley P
    Circulation; 1990 Jan; 81(1 Suppl):I69-78; discussion I79-80. PubMed ID: 2136820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Res; 1980; 6():493-6. PubMed ID: 7189952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.